A. B. Petersen

Zinc, alpha cells and glucagon secretion.

J. Rungby, Lærke Egefjord, A. B. Petersen, 2010, Current diabetes reviews.

SLC30A3 Responds to Glucose- and Zinc Variations in ß-Cells and Is Critical for Insulin Production and In Vivo Glucose-Metabolism During ß-Cell Stress

M. Stoltenberg, A. Bush, K. Smidt, 2009, PloS one.

siRNA‐mediated knock‐down of ZnT3 and ZnT8 affects production and secretion of insulin and apoptosis in INS‐1E cells

K. Smidt, J. Rungby, N. Magnusson, 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Adverse effects associated with high-dose olanzapine therapy in patients admitted to inpatient psychiatric care

M. Christensen, S. Andersen, A. B. Petersen, 2014, Clinical toxicology.

Clinical potential of lixisenatide once daily treatment for type 2 diabetes mellitus

M. Christensen, A. B. Petersen, 2013, Diabetes, metabolic syndrome and obesity : targets and therapy.

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

F. Pociot, K. Smidt, J. Rungby, 2009, BMC endocrine disorders.

siRNA‐mediated knock‐down of ZnT3 and ZnT8 affects production and secretion of insulin and apoptosis in INS‐1E cells

K. Smidt, J. Rungby, N. Magnusson, 2011, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis?

F. Pociot, K. Smidt, Lærke Egefjord, 2009, BMC Endocrine Disorders.

Lixisenatide for the treatment of type 2 diabetes.

M. Christensen, F. Knop, A. B. Petersen, 2013, Drugs of today.